Výsledky vyhledávání - "Cardiovascular"

Ideal Cardiovascular Health, Mortality, and Vascular Events in Elderly Subjects: The Three-City Study Autor Gaye, Bamba, Canonico, Marianne, Perier, Marie-Cécile, Samieri, Cecilia, Berr, Claudine, Dartigues, Jean-François, Tzourio, Christophe, Elbaz, Alexis, Empana, Jean-Philippe

“…The benefit of ideal cardiovascular health (CVH) on health-related outcomes in middle-aged patients is firmly established…”
Zjistit podrobnosti o přístupu

Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects Autor Ben-Shlomo, Yoav, Spears, Melissa, Boustred, Chris, May, Margaret, Anderson, Simon G, Benjamin, Emelia J, Boutouyrie, Pierre, Cameron, James, Chen, Chen-Huan, Cruickshank, J Kennedy, Hwang, Shih-Jen, Lakatta, Edward G, Laurent, Stephane, Maldonado, João, Mitchell, Gary F, Najjar, Samer S, Newman, Anne B, Ohishi, Mitsuru, Pannier, Bruno, Pereira, Telmo, Vasan, Ramachandran S, Shokawa, Tomoki, Sutton-Tyrell, Kim, Verbeke, Francis, Wang, Kang-Ling, Webb, David J, Willum Hansen, Tine, Zoungas, Sophia, McEniery, Carmel M, Cockcroft, John R, Wilkinson, Ian B

“…The goal of this study was to determine whether aortic pulse wave velocity (aPWV) improves prediction of cardiovascular disease…”
Zjistit podrobnosti o přístupu

Deep Learning-Based Quantification of Epicardial Adipose Tissue Volume and Attenuation Predicts Major Adverse Cardiovascular Events in Asymptomatic Subjects Autor Eisenberg, Evann, McElhinney, Priscilla A, Commandeur, Frederic, Chen, Xi, Cadet, Sebastien, Goeller, Markus, Razipour, Aryabod, Gransar, Heidi, Cantu, Stephanie, Miller, Robert J H, Slomka, Piotr J, Wong, Nathan D, Rozanski, Alan, Achenbach, Stephan, Tamarappoo, Balaji K, Berman, Daniel S, Dey, Damini

“…Epicardial adipose tissue (EAT) volume (cm ) and attenuation (Hounsfield units) may predict major adverse cardiovascular events (MACE…”
Zjistit podrobnosti o přístupu

Impact of sex on cardiovascular outcome in patients at high cardiovascular risk: analysis of the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects With Cardiovascular Disease (TRANSCEND) and the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial (ONTARGET) Autor Kappert, Kai, Böhm, Michael, Schmieder, Roland, Schumacher, Helmut, Teo, Koon, Yusuf, Salim, Sleight, Peter, Unger, Thomas

“…) and the parallel Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease (TRANSCEND…”
Zjistit podrobnosti o přístupu

Vitamin D Levels Predict All-Cause and Cardiovascular Disease Mortality in Subjects With the Metabolic Syndrome: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study Autor Thomas, G. Neil, ó Hartaigh, Bríain, Bosch, Jos A, Pilz, Stefan, Loerbroks, Adrian, Kleber, Marcus E, Fischer, Joachim E, Grammer, Tanja B, Böhm, Bernhard O, März, Winfried

“… RESEARCH DESIGN AND METHODS: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study is a cohort study of subjects referred for coronary angiography between 1997 and 2000, from which 1,801 with the metabolic syndrome were investigated…”
Získat plný text

Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study Autor Virani, Salim S, Brautbar, Ariel, Davis, Brian C, Nambi, Vijay, Hoogeveen, Ron C, Sharrett, A Richey, Coresh, Josef, Mosley, Thomas H, Morrisett, Joel D, Catellier, Diane J, Folsom, Aaron R, Boerwinkle, Eric, Ballantyne, Christie M

“…On the basis of studies with limited statistical power, lipoprotein(a) [Lp(a)] is not considered a risk factor for cardiovascular disease (CVD) in blacks…”
Zjistit podrobnosti o přístupu

Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk Autor Tardif, Jean-Claude, Karwatowska-Prokopczuk, Ewa, Amour, Eric St, Ballantyne, Christie M, Shapiro, Michael D, Moriarty, Patrick M, Baum, Seth J, Hurh, Eunju, Bartlett, Victoria J, Kingsbury, Joyce, Figueroa, Amparo L, Alexander, Veronica J, Tami, Joseph, Witztum, Joseph L, Geary, Richard S, O’Dea, Louis St L, Tsimikas, Sotirios, Gaudet, Daniel

“…Abstract Aims Hypertriglyceridaemia is associated with increased risk of cardiovascular events…”
Získat plný text

Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis Autor Savarese, Gianluigi, Gotto, Jr, Antonio M, Paolillo, Stefania, D'Amore, Carmen, Losco, Teresa, Musella, Francesca, Scala, Oriana, Marciano, Caterina, Ruggiero, Donatella, Marsico, Fabio, De Luca, Giuseppe, Trimarco, Bruno, Perrone-Filardi, Pasquale

“…The purpose of this paper was to assess whether statins reduce all-cause mortality and cardiovascular (CV…”
Zjistit podrobnosti o přístupu

Effects of long-term glycemic variability on incident cardiovascular disease and mortality in subjects without diabetes: A nationwide population-based study Autor Yu, Ji Hee, Han, Kyungdo, Park, Sanghyun, Lee, Da Young, Nam, Ga Eun, Seo, Ji A, Kim, Sin Gon, Baik, Sei Hyun, Park, Yong Gyu, Kim, Seon Mee, Kim, Nan Hee, Choi, Kyung Mook

“…Increased glycemic variability (GV) is an independent risk factor for cardiovascular complications in patients with diabetes…”
Získat plný text

The ESCAPER study—exploring protective mechanisms against cardiovascular disease in subjects at high risk: rationale, study protocol, and first results Autor Ekström, Ola, Arheden, Håkan, Christensson, Anders, Engström, Gunnar, Hedström, Erik, Kennbäck, Cecilia, Laucyte-Cibulskiene, Agne, Lundgren, Simon, Lyssenko, Valeriya, Löndahl, Magnus, Magnusson, Martin, Nilsson, Peter M., Gottsäter, Anders

“…The ESCAPER project explores cardiovascular resilience in individuals who, despite a high-risk factor burden-longstanding Type 1 Diabetes (T1D…”
Získat plný text

Chromium Exposure and Risk of Cardiovascular Disease in High Cardiovascular Risk Subjects　- Nested Case-Control Study in the Prevention With Mediterranean Diet (PREDIMED) Study Autor Gutiérrez-Bedmar, Mario, Martínez-González, Miguel Ángel, Muñoz-Bravo, Carlos, Ruiz-Canela, Miguel, Mariscal, Alberto, Salas-Salvadó, Jordi, Estruch, Ramón, Corella, Dolores, Arós, Fernando, Fito, Monserrat, Lapetra, José, Serra-Majem, Lluís, Pintó, Xavier, Alonso-Gómez, Ángel, Portoles, Olga, Fiol, Miquel, Bulló, Mónica, Castañer, Olga, Ros, Emilio, Gómez-Gracia, Enrique

“…Epidemiological data on chromium (Cr) exposure and the risk of cardiovascular disease (CVD) are still limited. Toenail Cr level (TCL…”
Zjistit podrobnosti o přístupu

Smoking cessation, weight control and cardiovascular disease: Letter in response to the article entitled “Sex-specific predictive factors of smoking cessation in subjects at high cardiovascular risk” by Allagbé et al Autor Kawada, Tomoyuki

Získat plný text

Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial Autor Sabatine, Marc S., Giugliano, Robert P., Keech, Anthony, Honarpour, Narimon, Wang, Huei, Liu, Thomas, Wasserman, Scott M., Scott, Robert, Sever, Peter S., Pedersen, Terje R.

“…Despite current therapies, patients with vascular disease remain at high risk for major adverse cardiovascular events…”
Získat plný text

Urinary Sodium Excretion, Blood Pressure, and Risk of Future Cardiovascular Disease and Mortality in Subjects Without Prior Cardiovascular Disease Autor Welsh, C E, Welsh, Paul, Jhund, Pardeep, Delles, Christian, Celis-Morales, C, Lewsey, J D, Gray, S, Lyall, D, Iliodromiti, S, Gill, J M R, Sattar, Naveed, Mark, Patrick B

“…Hypertension is a risk factor for cardiovascular disease. Increased urinary sodium excretion, representing dietary sodium intake, is associated with hypertension…”
Zjistit podrobnosti o přístupu

Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial Autor Leiter, Lawrence A., Bain, Stephen C., Hramiak, Irene, Jódar, Esteban, Madsbad, Sten, Gondolf, Theis, Hansen, Thomas, Holst, Ingrid, Lingvay, Ildiko

“…Background The SUSTAIN 6 trial demonstrated that once-weekly semaglutide (0.5 and 1.0 mg) significantly reduced major adverse cardiovascular…”
Získat plný text

UK Biobank: opportunities for cardiovascular research Autor Littlejohns, Thomas J, Sudlow, Cathie, Allen, Naomi E, Collins, Rory

Získat plný text

Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials Autor Böhm, Michael, Baumhäkel, Magnus, Teo, Koon, Sleight, Peter, Probstfield, Jeffrey, Gao, Peggy, Mann, Johannes F, Diaz, Rafael, Dagenais, Gilles R, Jennings, Garry L R, Liu, Lisheng, Jansky, Petr, Yusuf, Salim

“…Although erectile dysfunction (ED) is associated with cardiovascular risk factors and atherosclerosis, it is not known whether the presence of ED is predictive of future events in individuals with cardiovascular disease…”
Zjistit podrobnosti o přístupu

Infradian cardiovascular rhythms and between subject cardiovascular coupling in Mars500 prolonged confinement study Autor Vigo, Daniel Eduardo, Tuerlinckx, Francis, Scaramal, Mariano, Reimann Baptista, Rafael, Bersenev, Evgeny, Van den Bergh, Omer, Aubert, André E.

“…The aim of this study was to characterize infradian rhythms in heart rate and blood pressure, as well as investigate potential synchronization of these…”
Získat plný text

Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk) Autor Bonaca, Marc P, Nault, Patrice, Giugliano, Robert P, Keech, Anthony C, Pineda, Armando Lira, Kanevsky, Estella, Kuder, Julia, Murphy, Sabina A, Jukema, J Wouter, Lewis, Basil S, Tokgozoglu, Lale, Somaratne, Ransi, Sever, Peter S, Pedersen, Terje R, Sabatine, Marc S

“… (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk…”
Zjistit podrobnosti o přístupu

Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion Autor Brantsma, Auke H, Bakker, Stephan J L, Hillege, Hans L, de Zeeuw, Dick, de Jong, Paul E, Gansevoort, Ronald T

“…) in stage 3 suggests a higher cardiovascular and renal risk. In this study we evaluated cardiovascular and renal outcome in subjects with stage 1 and 2 CKD…”
Zjistit podrobnosti o přístupu